Clinical Trials
3 trialsNCT03685591 2024-06-26
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Pfizer
Phase 1 Terminated
NCT04297748 2023-01-17
Bioimaging Study of 89Zr-M7824 in NSCLC
Olivia Newton-John Cancer Research Institute
Phase 1/2 Terminated
NCT04158700 2020-02-19
A Study of LY3200882 and Pembrolizumab in Participants With Advanced Cancer
Eli Lilly and Company
Phase 1/2 Withdrawn